Zomedica Receives Formal Notice That It Is Not In Compliance With NYSE American's Continued Listing Standard
Portfolio Pulse from Benzinga Newsdesk
Zomedica has received a formal notice from NYSE American stating that it is not in compliance with the exchange's continued listing standard. The company's failure to meet the standard could potentially lead to its delisting.
September 13, 2023 | 8:34 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Zomedica's non-compliance with NYSE American's listing standard could lead to its delisting, which would likely negatively impact its stock price.
Being in non-compliance with the listing standards of an exchange is a serious issue for any publicly traded company. If Zomedica is unable to rectify this situation, it could be delisted from the NYSE American, which would likely result in a significant drop in its stock price as it would become more difficult for investors to buy or sell the company's shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100